<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.asir-journal.com/feeds/mostaccessed/journal?quantity=&amp;format=rss&amp;version=">
        <title>Annals of Surgical Innovation and Research - Most accessed articles</title>
        <link>http://www.asir-journal.com</link>
        <description>The most accessed research articles published by Annals of Surgical Innovation and Research</description>
        <dc:date>2009-12-31T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.asir-journal.com/content/3/1/1" />
                                <rdf:li rdf:resource="http://www.asir-journal.com/content/3/1/12" />
                                <rdf:li rdf:resource="http://www.asir-journal.com/content/3/1/15" />
                                <rdf:li rdf:resource="http://www.asir-journal.com/content/3/1/7" />
                                <rdf:li rdf:resource="http://www.asir-journal.com/content/3/1/8" />
                                <rdf:li rdf:resource="http://www.asir-journal.com/content/3/1/17" />
                                <rdf:li rdf:resource="http://www.asir-journal.com/content/3/1/14" />
                                <rdf:li rdf:resource="http://www.asir-journal.com/content/3/1/16" />
                                <rdf:li rdf:resource="http://www.asir-journal.com/content/3/1/11" />
                                <rdf:li rdf:resource="http://www.asir-journal.com/content/3/1/10" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.asir-journal.com/content/3/1/1">
        <title>Management of complications after laparoscopic Nissen&apos;s fundoplication: a surgeon&apos;s perspective</title>
        <description>IntroductionGastro-oesophageal reflux disease (GORD) is a common problem in the Western countries, and the interest in the minimal access surgical approaches to treat GORD is increasing. In this study, we would like to discuss the presentations and management of complications we encountered after Laparoscopic Nissen&apos;s fundoplication in our District General NHS Hospital. The aim is to recognise these complications at the earliest stage for effective management to minimise the morbidity and mortality.
Methods:
301 patients underwent laparoscopic treatment for GORD by a single consultant surgeon in our NHS Trust from September 1999. The data was prospectively collected and entered into a database. The data was retrospectively analysed for presentations for complications and their management.
Results:
Surgery was completed laparoscopically in all patients, except in five, where the operation was technically difficult due to pre-existing conditions. The complications we encountered during surgery and follow-up period were major intra-operative bleeding (n = 1, 0.33%), severe post-operative nausea and vomiting (n = 1, 0.33%), wound infection (n = 3, 1%), port-site herniation (n = 1, 0.33%), wrap-migration (n = 2, 0.66%), wrap-ischaemia (n = 1, 0.33%), recurrent regurgitation (n = 4, 1.32%), recurrent heartburn (n = 29, 9.63%), tension pneumothorax (n = 2, 0.66%), surgical emphysema (n = 8, 2.66%), and port-site pain (n = 4, 1.33%).
Conclusion:
Minimal access approach to treat GORD has presented with some specific and unique complications. It is important to recognise these complications at the earliest possible stage as some of these patients may present in an acute setting requiring emergency surgery. All members of the department, and not just the members of the specialised team, should be aware about these complications to minimise the morbidity and mortality.</description>
        <link>http://www.asir-journal.com/content/3/1/1</link>
                <dc:creator>Tarun Singhal</dc:creator>
                <dc:creator>Santosh Balakrishnan</dc:creator>
                <dc:creator>Abdulzahra Hussain</dc:creator>
                <dc:creator>Starlene Grandy-Smith</dc:creator>
                <dc:creator>Andrew Paix</dc:creator>
                <dc:creator>Shamsi El-Hasani</dc:creator>
                <dc:source>Annals of Surgical Innovation and Research 2009, 3:1</dc:source>
        <dc:date>2009-02-04T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1750-1164-3-1</dc:identifier>
        <prism:publicationName>Annals of Surgical Innovation and Research</prism:publicationName>
        <prism:issn>1750-1164</prism:issn>
        <prism:volume>3</prism:volume>
        <prism:startingPage>1</prism:startingPage>
        <prism:publicationDate>2009-02-04T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.asir-journal.com/content/3/1/12">
        <title>Fibrin glue in the treatment of anal fistula: a systematic review</title>
        <description>Background:
New sphincter-saving approaches have been applied in the treatment of perianal fistula in order to avoid the risk of fecal incontinence. Among them, the fibrin glue technique is popular because of its simplicity and repeatability. The aim of this review is to compare the fibrin glue application to surgery alone, considering the healing and complication rates.
Methods:
We performed a systematic review searching for published randomized and controlled clinical trials without any language restriction by using electronic databases. All these studies were assessed as to whether they compared conventional surgical treatment versus fibrin glue treatment in patients with anal fistulas, in order to establish both the efficacy and safety of each treatment. We used Review Manager 5 to conduct the review.
Results:
The healing rate is higher in those patients who underwent the conventional surgical treatment (P = 0,68), although the treatment with fibrin glue gives no evidence of anal incontinence (P = 0,08). Furthermore two subgroup analyses were performed: fibrin glue in combination with intra-adhesive antibiotics versus fibrin glue alone and anal fistula plug versus fibrin glue. In the first subgroup there were not differences in healing (P = 0,65). Whereas in the second subgroup analysis the healing rate is statistically significant for the patients who underwent the anal fistula plug treatment instead of the fibrin glue treatment (P = 0,02).
Conclusion:
In literature there are only two randomized controlled trials comparing the conventional surgical management versus the fibrin glue treatment in patients with anal fistulas. Although from our statistical analysis we cannot find any statistically significant result, the healing rate remains higher in patients who underwent the conventional surgical treatment (P = 0,68), and the anal incontinence rate is very low in the fibrin glue treatment group (P = 0,08). Anyway the limited collected data do not support the use of fibrin glue. Moreover, in our subgroup analysis the use of fibrin glue in combination with intra-adhesive antibiotics does not improve the healing rate (P = 0.65), whereas the anal fistula plug treatment compared to the fibrin glue treatment shows good results (P = 0,02), although the poor number of patients treated does not lead to any statistically evident conclusion. This systematic review underlines the need of new RCTs upon this issue.</description>
        <link>http://www.asir-journal.com/content/3/1/12</link>
                <dc:creator>Roberto Cirocchi</dc:creator>
                <dc:creator>Eriberto Farinella</dc:creator>
                <dc:creator>Francesco La Mura</dc:creator>
                <dc:creator>Lorenzo Cattorini</dc:creator>
                <dc:creator>Barbara Rossetti</dc:creator>
                <dc:creator>Diego Milani</dc:creator>
                <dc:creator>Patrizia Ricci</dc:creator>
                <dc:creator>Piero Covarelli</dc:creator>
                <dc:creator>Marco Coccetta</dc:creator>
                <dc:creator>Giuseppe Noya</dc:creator>
                <dc:creator>Francesco Sciannameo</dc:creator>
                <dc:source>Annals of Surgical Innovation and Research 2009, 3:12</dc:source>
        <dc:date>2009-11-14T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1750-1164-3-12</dc:identifier>
        <prism:publicationName>Annals of Surgical Innovation and Research</prism:publicationName>
        <prism:issn>1750-1164</prism:issn>
        <prism:volume>3</prism:volume>
        <prism:startingPage>12</prism:startingPage>
        <prism:publicationDate>2009-11-14T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.asir-journal.com/content/3/1/15">
        <title>Emergency treatment of complicated incisional hernias: a case study</title>
        <description>Background:
The emergency treatment of incisional hernias is infrequent but it can be complicated with strangulation or obstruction and in some cases the surgical approach may also include an intestinal resection with the possibility of peritoneal contamination. Our study aims at reporting our experience in the emergency treatment of complicated incisional hernias.
Methods:
Since January 1999 till July 2008, 89 patients (55 males and 34 females) were treated for complicated incisional hernias in emergency. The patients were divided in two groups: Group I consisting of 33 patients that were treated with prosthesis apposition and Group II, consisting of 56 patients that were treated by performing a direct abdominal wall muscles suture.
Results:
All the patients underwent a 6-month follow up; we noticed 9 recurrences (9/56, 16%) in the patients treated with direct abdominal wall muscles suture and 1 recurrence (1/33, 3%) in the group of patients treated with the prosthesis apposition.
Conclusions:
According to our experience, the emergency treatment of complicated incisional hernias through prosthesis apposition is always feasible and ensures less post-operative complications (16% vs 21,2%) and recurrences (3% vs 16%) compared to the patients treated with direct muscular suture.</description>
        <link>http://www.asir-journal.com/content/3/1/15</link>
                <dc:creator>Francesco La Mura</dc:creator>
                <dc:creator>Roberto Cirocchi</dc:creator>
                <dc:creator>Eriberto Farinella</dc:creator>
                <dc:creator>Umberto Morelli</dc:creator>
                <dc:creator>Vincenzo Napolitano</dc:creator>
                <dc:creator>Lorenzo Cattorini</dc:creator>
                <dc:creator>Alessandro Spizzirri</dc:creator>
                <dc:creator>Barbara Rossetti</dc:creator>
                <dc:creator>Pamela Delmonaco</dc:creator>
                <dc:creator>Carla Migliaccio</dc:creator>
                <dc:creator>Diego Milani</dc:creator>
                <dc:creator>Piero Covarelli</dc:creator>
                <dc:creator>Carlo Boselli</dc:creator>
                <dc:creator>Giuseppe Noya</dc:creator>
                <dc:creator>Francesco Sciannameo</dc:creator>
                <dc:source>Annals of Surgical Innovation and Research 2009, 3:15</dc:source>
        <dc:date>2009-12-17T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1750-1164-3-15</dc:identifier>
        <prism:publicationName>Annals of Surgical Innovation and Research</prism:publicationName>
        <prism:issn>1750-1164</prism:issn>
        <prism:volume>3</prism:volume>
        <prism:startingPage>15</prism:startingPage>
        <prism:publicationDate>2009-12-17T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.asir-journal.com/content/3/1/7">
        <title>A versatile breast reduction technique: Conical plicated central U shaped (COPCUs) mammaplasty</title>
        <description>Background:
There have been numerous studies on reduction mammaplasty and its modifications in the literature. The multitude of modifications of reduction mammaplasty indicates that the ideal technique has yet to be found. There are four reasons for seeking the ideal technique. One reason is to preserve functional features of the breast: breastfeeding and arousal. Other reasons are to achieve the real geometric and aesthetic shape of the breast with the least scar and are to minimize complications of prior surgical techniques without causing an additional complication. Last reason is the limitation of the techniques described before. To these aims, we developed a new versatile reduction mammaplasty technique, which we called conical plicated central U shaped (COPCUs) mammaplasty.
Methods:
We performed central plication to achieve a juvenile look in the superior pole of the breast and to prevent postoperative pseudoptosis and used central U shaped flap to achieve maximum NAC safety and to preserve lactation and nipple sensation. The central U flap was 6 cm in width and the superior conical plication was performed with 2/0 PDS. Preoperative and postoperative standard measures of the breast including the superior pole fullness were compared.
Results:
Forty six patients were operated with the above mentioned technique. All of the patients were satisfied with functional and aesthetic results and none of them had major complications. There were no changes in the nipple innervation. Six patients becoming pregnant after surgery did not experience any problems with lactation. None of the patients required scar revision.
Conclusion:
Our technique is a versatile, safe, reliable technique which creates the least scar, avoids previously described disadvantages, provides maximum preservation of functions, can be employed in all breasts regardless of their sizes.</description>
        <link>http://www.asir-journal.com/content/3/1/7</link>
                <dc:creator>Eray Copcu</dc:creator>
                <dc:source>Annals of Surgical Innovation and Research 2009, 3:7</dc:source>
        <dc:date>2009-07-03T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1750-1164-3-7</dc:identifier>
        <prism:publicationName>Annals of Surgical Innovation and Research</prism:publicationName>
        <prism:issn>1750-1164</prism:issn>
        <prism:volume>3</prism:volume>
        <prism:startingPage>7</prism:startingPage>
        <prism:publicationDate>2009-07-03T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.asir-journal.com/content/3/1/8">
        <title>Contamination of equipment in emergency settings: An exploratory study with a targeted automated intervention</title>
        <description>Background:
Despite standard manual decontamination, hospital equipment remains contaminated with microorganisms, contributing to nosocomial transmission and hospital acquired infections. This has the potential to negate the effects of healthcare workers&apos; hand-washing protocols. In order to decrease the likihood of equipment contamination, there has been a rise in the use of disposable pieces of equipment, especially non-critical disposables. However, these carry a significant cost, both a direct financial cost (running into billions of dollars), as well as a cost to the environment. This is important because we hope to contain the cost of healthcare, one way to do that, is to look to the hospitals themselves, for innovative solutions that maintain the standard of care.ObjectiveTo develop and evaluate the effectiveness of an simple decontamination device for use with portable hospital equipment, by comparing rates of residual contamination after use of the novel device versus those seen with standard manual decontamination methods.
Methods:
The Self-cleaning Unit for the Decontamination of Small instruments (SUDS) is a user-friendly, automated instrument developed via multi-disciplinary collaboration for decontamination in the clinical area. Pre- and post- utilization of portable medical equipment in an emergency department (ED) setting were cultured. To evaluate durability of the decrease in antimicrobial contamination, objects were re-cultured 48 hours after SUDS cleaning and following re-introduction into the clinical setting.
Results:
After manual decontamination, 25% (23/91) of the tested objects in the ED were found to be culture positive with clinically significant microorganisms(CSO). Fifteen percent (ED) of non-critical equipment tested had multiple organisms. Following the use of SUDS, the colonization rate decreased to 0%. Following SUDS treatment and re-introduction into the clinical settings, after 48 hours the contamination rates as reflected by the cultures remained 0%.
Conclusion:
Standard non-critical equipment is contaminated with clinically significant microorganisms. The SUDS device allows for effective and durable decontamination of hospital equipment of varying sizes in the clinical area without disrupting patient care.</description>
        <link>http://www.asir-journal.com/content/3/1/8</link>
                <dc:creator>Chidi Obasi</dc:creator>
                <dc:creator>Allison Agwu</dc:creator>
                <dc:creator>Wale Akinpelu</dc:creator>
                <dc:creator>Roger Hammons</dc:creator>
                <dc:creator>Clyde Clark</dc:creator>
                <dc:creator>Ralph Etienne-cummings</dc:creator>
                <dc:creator>Peter Hill</dc:creator>
                <dc:creator>Richard Rothman</dc:creator>
                <dc:creator>Stella Babalola</dc:creator>
                <dc:creator>Tracy Ross</dc:creator>
                <dc:creator>Karen Carroll</dc:creator>
                <dc:creator>Bolanle Asiyanbola</dc:creator>
                <dc:source>Annals of Surgical Innovation and Research 2009, 3:8</dc:source>
        <dc:date>2009-07-30T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1750-1164-3-8</dc:identifier>
        <prism:publicationName>Annals of Surgical Innovation and Research</prism:publicationName>
        <prism:issn>1750-1164</prism:issn>
        <prism:volume>3</prism:volume>
        <prism:startingPage>8</prism:startingPage>
        <prism:publicationDate>2009-07-30T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.asir-journal.com/content/3/1/17">
        <title>Microdialysis assessment of peripheral metabolism in critical limb ischemia after endovascular revascularization</title>
        <description>Background:
Critical limb ischemia is a chronic pathologic condition defined by the lack of blood flow in peripheral circulation. Microdialysis is a well-known and sensitive method for the early detection of tissue ischemia. The aim of the present study was to use microdialysis in order to analyse cellular metabolism changes after peripheral endovascular revascularization.
Methods:
Ten patients diagnosed with critical limb ischemia was enrolled. CMA 60 (CMA&#174; - Solna, Sweden) catheter with a 20 kDa cut-off was placed subcutaneously on the anterior aspect of the foot of both limbs. Samples were collected starting 12-hours before surgery and throughout the following 72-hours, using a CMA 600 (CMA&#174; - Solna, Sweden) microdialysis analyser.
Results:
Technical revascularization was successful in all cases. The cannulation was well tolerated in all patients. The site of catheter insertion healed easily in few days without infective complications in any case. Two patients underwent major amputation. After revascularization, glucose showed a strong increase (mean, 5.86 &#177; 1.52 mMol/L, p = .008). No restoration of the circadian rhythm was noted in patients who underwent major amputation. Glycerol concentration curves were not deductibles in both the ischemic and the control limbs (mean, 148.43 &#177; 42.13 mMol/L vs 178.44 &#177; 75.93 mMol/L, p = .348). Within the first 24-hours after revascularization, lactate concentration raised strongly (6.58 &#177; 1.56 mMol/L, p = .002): thereafter, it immediately decreased to a concentration similar to the control level (1.71 &#177; 1.69 mMol/L). In both patients who underwent major amputation, lactate did not show the typical peak of the successful revascularization. The trend of the lactate/pyruvate ratio after a brief initial decrease of the ratio increased again in both the patients who finally underwent amputation.
Conclusions:
Restoration of glucose and glycerol circadian rhythm, coupled with low lactate concentration and lactate/pyruvate ratio seemed to be linked to good surgical outcome.</description>
        <link>http://www.asir-journal.com/content/3/1/17</link>
                <dc:creator>Matteo Tozzi</dc:creator>
                <dc:creator>Elisa Muscianisi</dc:creator>
                <dc:creator>Gabriele Piffaretti</dc:creator>
                <dc:creator>Patrizio Castelli</dc:creator>
                <dc:source>Annals of Surgical Innovation and Research 2009, 3:17</dc:source>
        <dc:date>2009-12-31T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1750-1164-3-17</dc:identifier>
        <prism:publicationName>Annals of Surgical Innovation and Research</prism:publicationName>
        <prism:issn>1750-1164</prism:issn>
        <prism:volume>3</prism:volume>
        <prism:startingPage>17</prism:startingPage>
        <prism:publicationDate>2009-12-31T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.asir-journal.com/content/3/1/14">
        <title>Topical recombinant thrombin at a concentration of 1000 IU/mL reliably shortens in vivo TTH and delivers durable hemostasis in the presence of heparin anticoagulation and clopidogrel platelet inhibition in a rabbit model of vascular bleeding</title>
        <description>Background:
This study was designed to evaluate the effect of recombinant human thrombin (rThrombin) concentration on time to hemostasis (TTH), clot durability, and clot strength in settings that replicate the heparinization and platelet inhibition often found in surgical populations.
Methods:
A modified, anticoagulated rabbit arteriovenous shunt preparation was selected to model vascular anastomotic bleeding. Rabbits were treated with heparin or heparin&#160;+&#160;clopidogrel and TTH was measured after applying a range of topical rThrombin concentrations or placebo, in combination with absorbable gelatin sponge, USP. Treatments (placebo, rThrombin) were randomly assigned and the investigator was blinded to treatment. TTH was evaluated with the Kaplan-Meier method. After hemostasis was achieved, clot burst assessment was performed for heparin&#160;+&#160;clopidogrel treated animals. Clot viscoelastic strength and kinetics were measured in ex-vivo samples using thromboelastography (TEG) methods.
Results:
TTH decreased with increasing concentrations of rThrombin in heparin-treated animals and was shorter after treatment with 1000&#160;IU/mL rThrombin (73&#160;seconds) than with 125&#160;IU/mL rThrombin (78&#160;seconds; p&#160;=&#160;0.007). TTH also decreased with increasing concentrations of rThrombin in heparin&#160;+&#160;clopidogrel treated animals; again it was significantly shorter after treatment with 1000&#160;IU/mL rThrombin (71&#160;seconds) than with 125&#160;IU/mL rThrombin (177&#160;seconds; p&#160;&lt;&#160;0.001). Variability in TTH was significantly smaller after treatment with 1000&#160;IU/mL rThrombin than after 125&#160;IU/mL rThrombin, indicating greater reliability of clot formation (p&#160;&lt;&#160;0.001 for heparin or heparin&#160;+&#160;clopidogrel treatments). Clot durability was examined in heparin&#160;+&#160;clopidogrel treated animals. Clots formed in the presence of 1000&#160;IU/mL rThrombin were significantly less likely to rupture during clot burst assessment than those formed in the presence of 125&#160;IU/mL rThrombin (0% versus 79%, p&#160;&lt;&#160;0.001). In vitro clot strength and clot kinetics, as determined by TEG in heparin&#160;+&#160;clopidogrel samples, were positively associated with the amount of rThrombin activity added for clot initiation.
Conclusion:
In an animal model designed to replicate the anti-coagulation regimens encountered in clinical settings, topical rThrombin at 1000&#160;IU/mL more reliably controlled the pharmacological effects of heparin or heparin&#160;+&#160;clopidogrel on hemostasis than rThrombin at 125&#160;IU/mL. Results from in vitro assessments confirmed a positive relationship between the amount of rThrombin activity and both the rate of clot formation and clot strength.</description>
        <link>http://www.asir-journal.com/content/3/1/14</link>
                <dc:creator>Steven Hughes</dc:creator>
                <dc:creator>Paul Bishop</dc:creator>
                <dc:creator>Richard Garcia</dc:creator>
                <dc:creator>Tracy Zhang</dc:creator>
                <dc:creator>W. Allan Alexander</dc:creator>
                <dc:source>Annals of Surgical Innovation and Research 2009, 3:14</dc:source>
        <dc:date>2009-11-19T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1750-1164-3-14</dc:identifier>
        <prism:publicationName>Annals of Surgical Innovation and Research</prism:publicationName>
        <prism:issn>1750-1164</prism:issn>
        <prism:volume>3</prism:volume>
        <prism:startingPage>14</prism:startingPage>
        <prism:publicationDate>2009-11-19T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.asir-journal.com/content/3/1/16">
        <title>Increased liver regeneration rate and decreased liver function after synchronous liver and colon resection in rats</title>
        <description>Background:
The surgical strategy for the treatment of colorectal cancer and synchronous liver metastases remains controversial. The aim of the present study was to investigate the effects of colonic resection on liver function and regeneration in a rat model.
Methods:
Ninety-six Sprague-Dawley rats were block-randomized into six groups: Group I had a laparotomy performed. Group II had 1 cm colon resected and anastomosed. Group III and V had 40% or 70% of the liver resected, respectively. Additionally Group IV and VI had 1 cm colon resected and anastomosed, respectively. Body weight was recorded on postoperative day 0, 3, 5 and 7. Rats were sacrificed on postoperative day 7 by rapid collection of blood from the inferior vena cava, and endotoxin levels were measured. Remnant liver function was evaluated by means of branched amino acids to tyrosine ratio. Liver regeneration was calculated by (liver weight per 100 g of the body weight at sacrifice/preoperative projected liver weight per 100 g of the body weight) &#215; 100.
Results:
The total number of complications was significantly higher in Group VI than Group I, III, IV, and V. Body weight and branched amino acids to tyrosine ratio were both significantly lower in rats that had simultaneous colonic and liver resection performed. Hepatic regeneration rate was significantly higher in the simultaneous colectomy group. Systemic endotoxin levels were unaffected by simultaneous colectomy on postoperative day 7.
Conclusions:
In our model morbidity seems to be related to the extent of hepatic resection. In rats undergoing liver resection, simultaneous colectomy induced a higher degree of hepatic regeneration rate. Body weight changes and branched amino acids to tyrosine ratio were negatively affected by simultaneous colectomy.</description>
        <link>http://www.asir-journal.com/content/3/1/16</link>
                <dc:creator>Hideki Sasanuma</dc:creator>
                <dc:creator>Frank Mortensen</dc:creator>
                <dc:creator>Anders Knudsen</dc:creator>
                <dc:creator>Peter Funch-Jensen</dc:creator>
                <dc:creator>Masaki Okada</dc:creator>
                <dc:creator>Hideo Nagai</dc:creator>
                <dc:creator>Yoshikazu Yasuda</dc:creator>
                <dc:source>Annals of Surgical Innovation and Research 2009, 3:16</dc:source>
        <dc:date>2009-12-24T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1750-1164-3-16</dc:identifier>
        <prism:publicationName>Annals of Surgical Innovation and Research</prism:publicationName>
        <prism:issn>1750-1164</prism:issn>
        <prism:volume>3</prism:volume>
        <prism:startingPage>16</prism:startingPage>
        <prism:publicationDate>2009-12-24T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.asir-journal.com/content/3/1/11">
        <title>Virtual colonoscopy in stenosing colorectal cancer</title>
        <description>Background:
Between 5 and 10% of the patients undergoing a colonoscopy cannot have a complete procedure mainly due to stenosing neoplastic lesion of rectum or distal colon. Nevertheless the elective surgical treatment concerning the stenosis is to be performed after the pre-operative assessment of the colonic segments upstream the cancer.The aim of this study is to illustrate our experience with the Computed Tomographic Colonography (CTC) for the pre-operative assessment of the entire colon in the patients with stenosing colorectal cancers.
Methods:
From January 2005 till March 2009, we observed and treated surgically 43 patients with stenosing colorectal neoplastic lesions. All patients did not tolerate the pre-operative colonoscopy. For this reason they underwent a pre-operative CTC in order to have a complete assessment of the entire colon. All patients underwent a follow-up colonoscopy 3 months after the surgical treatment. The CTC results were compared with both macroscopic examination of the specimen and the follow-up coloscopy.
Results:
The pre-operative CTC showed four synchronous lesions in four patients (9.3% of the cases). The macroscopic examination of the specimen revealed three small sessile polyps (3 - 4 mm in diameter) missed in the pre-operative assessment near the stenosing colorectal cancer. The follow-up colonoscopy showed four additional sessile polyps with a diameter between 3 - 11 mm in three patients.Our experience shows that CTC has a sensitivity of 83,7%.
Conclusion:
In patients with stenosing colonic lesions, CTC allows to assess the entire colon pre-operatively avoiding the need of an intraoperative colonoscopy. More synchronous lesions are detected and treated at the time of the elective surgery for the stenosing cancer avoiding further surgery later on.</description>
        <link>http://www.asir-journal.com/content/3/1/11</link>
                <dc:creator>Marco Coccetta</dc:creator>
                <dc:creator>Carla Migliaccio</dc:creator>
                <dc:creator>Francesco La Mura</dc:creator>
                <dc:creator>Eriberto Farinella</dc:creator>
                <dc:creator>Ioanna Galanou</dc:creator>
                <dc:creator>Pamela Del Monaco</dc:creator>
                <dc:creator>Alessandro Spizzirri</dc:creator>
                <dc:creator>Vincenzo Napolitano</dc:creator>
                <dc:creator>Alessandro Spizzirri</dc:creator>
                <dc:creator>Diego Milani</dc:creator>
                <dc:creator>Roberto Cirocchi</dc:creator>
                <dc:creator>Francesco Sciannameo</dc:creator>
                <dc:source>Annals of Surgical Innovation and Research 2009, 3:11</dc:source>
        <dc:date>2009-11-09T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1750-1164-3-11</dc:identifier>
        <prism:publicationName>Annals of Surgical Innovation and Research</prism:publicationName>
        <prism:issn>1750-1164</prism:issn>
        <prism:volume>3</prism:volume>
        <prism:startingPage>11</prism:startingPage>
        <prism:publicationDate>2009-11-09T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.asir-journal.com/content/3/1/10">
        <title>Antibiotic prophylaxis in thyroid surgery: a preliminary multicentric italian experience

</title>
        <description>Post-operatory wound infections are a very uncommon finding after thyroidectomy. For these reasons international guidelines do not routinely recommend systemic antibiotic prophylaxis.The benefits of this antibiotic prophylaxis is not supported by clinical evidence in the literature. We have conducted a multicentric randomized double-blind trial on 500 patients who had undergone thyroidectomy for goitre or thyroid carcinoma. The 500 patients enrolled in the study (mean age 47 years) were randomized in two subgroups of 250 patients. 250 patients were treated with standard antibiotic prophylaxis with sulbactam/ampicillin 1 fl (3 gr.) 30 min before surgery. No antibiotic prophylaxis was instituted in the remainder 250 patients. Our RCT showed that prophylactic antibiotic treatment is not beneficial in patients younger than eighty years old, with no concomitant metabolic, infective and hematologic disease, with no cardiac valvulopathies, not under steroidal or immunosuppressive treatment, and not severely obese. Our study should be regarded only as a preliminary RCT, and should be followed by a study in which a larger number of patients should be enrolled so that statistically significant data can be obtained.</description>
        <link>http://www.asir-journal.com/content/3/1/10</link>
                <dc:creator>Nicola Avenia</dc:creator>
                <dc:creator>Alessandro Sanguinetti</dc:creator>
                <dc:creator>Roberto Cirocchi</dc:creator>
                <dc:creator>Giovanni Docimo</dc:creator>
                <dc:creator>Mark Ragusa</dc:creator>
                <dc:creator>Roberto Ruggiero</dc:creator>
                <dc:creator>Eugenio Procaccini</dc:creator>
                <dc:creator>Carlo Boselli</dc:creator>
                <dc:creator>Fabio D'Ajello</dc:creator>
                <dc:creator>Francesco Barberini</dc:creator>
                <dc:creator>Domenico Parmeggiani</dc:creator>
                <dc:creator>Lodovico Rosato</dc:creator>
                <dc:creator>Francesco Sciannameo</dc:creator>
                <dc:creator>Giorgio De Toma</dc:creator>
                <dc:creator>Giuseppe Noya</dc:creator>
                <dc:source>Annals of Surgical Innovation and Research 2009, 3:10</dc:source>
        <dc:date>2009-08-05T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1750-1164-3-10</dc:identifier>
        <prism:publicationName>Annals of Surgical Innovation and Research</prism:publicationName>
        <prism:issn>1750-1164</prism:issn>
        <prism:volume>3</prism:volume>
        <prism:startingPage>10</prism:startingPage>
        <prism:publicationDate>2009-08-05T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
